Orient EuroPharma Co., Ltd.

TPEX:4120 Stock Report

Market Cap: NT$4.2b

Orient EuroPharma Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Orient EuroPharma.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth16.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Here's Why Orient EuroPharma (GTSM:4120) Has A Meaningful Debt Burden

Apr 04
Here's Why Orient EuroPharma (GTSM:4120) Has A Meaningful Debt Burden

Is Orient EuroPharma Co., Ltd.'s (GTSM:4120) 3.3% Dividend Worth Your Time?

Mar 04
Is Orient EuroPharma Co., Ltd.'s (GTSM:4120) 3.3% Dividend Worth Your Time?

A Look At Orient EuroPharma's (GTSM:4120) Share Price Returns

Feb 10
A Look At Orient EuroPharma's (GTSM:4120) Share Price Returns

Is Orient EuroPharma Co., Ltd.'s (GTSM:4120) Recent Performancer Underpinned By Weak Financials?

Jan 22
Is Orient EuroPharma Co., Ltd.'s (GTSM:4120) Recent Performancer Underpinned By Weak Financials?

We Think Orient EuroPharma (GTSM:4120) Can Stay On Top Of Its Debt

Jan 04
We Think Orient EuroPharma (GTSM:4120) Can Stay On Top Of Its Debt

A Look At The Fair Value Of Orient EuroPharma Co., Ltd. (GTSM:4120)

Dec 17
A Look At The Fair Value Of Orient EuroPharma Co., Ltd. (GTSM:4120)

Are Dividend Investors Getting More Than They Bargained For With Orient EuroPharma Co., Ltd.'s (GTSM:4120) Dividend?

Nov 29
Are Dividend Investors Getting More Than They Bargained For With Orient EuroPharma Co., Ltd.'s (GTSM:4120) Dividend?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Orient EuroPharma has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TPEX:4120 - Analysts future estimates and past financials data (TWD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20244,54526-122-17N/A
12/31/20234,59214420121N/A
9/30/20234,663-246-498-268N/A
6/30/20234,668-398-379-148N/A
3/31/20234,738-307-532-331N/A
12/31/20224,730-311-860-219N/A
9/30/20224,727-93-1,41437N/A
6/30/20224,76747-1,51698N/A
3/31/20224,696138-1,543441N/A
12/31/20214,767120-1,49078N/A
9/30/20214,808-82-63048N/A
6/30/20214,835-48-526-21N/A
3/31/20215,0498765187N/A
12/31/20205,384199373609N/A
9/30/20205,664266156363N/A
6/30/20205,966311187441N/A
3/31/20206,141236176463N/A
12/31/20196,09324849227N/A
9/30/20195,929233-73132N/A
6/30/20195,832286-62101N/A
3/31/20195,648243-257-69N/A
12/31/20185,51024727231N/A
9/30/20185,396241194322N/A
6/30/20185,363319108305N/A
3/31/20185,260418427644N/A
12/31/20175,226459N/A601N/A
9/30/20175,272585N/A626N/A
6/30/20175,209504N/A559N/A
3/31/20175,267471N/A206N/A
12/31/20165,232470N/A111N/A
9/30/20165,050362N/A489N/A
6/30/20165,032322N/A576N/A
3/31/20164,878272N/A680N/A
12/31/20154,907223N/A644N/A
9/30/20154,982216N/A375N/A
6/30/20155,035230N/A518N/A
3/31/20155,121253N/A414N/A
12/31/20145,000196N/A325N/A
9/30/20144,851123N/A65N/A
6/30/20144,645195N/A-169N/A
3/31/20144,619436N/A-208N/A
12/31/20134,665507N/A-28N/A
9/30/20134,650593N/A359N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 4120's forecast earnings growth is above the savings rate (1%).

Earnings vs Market: Insufficient data to determine if 4120's earnings are forecast to grow faster than the TW market

High Growth Earnings: Insufficient data to determine if 4120's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 4120's revenue is forecast to grow faster than the TW market.

High Growth Revenue: Insufficient data to determine if 4120's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 4120's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.